Surfactant alterations in horses with recurrent airway obstruction at various clinical stages
- 1 April 2010
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 71 (4), 468-475
- https://doi.org/10.2460/ajvr.71.4.468
Abstract
Objective—To evaluate the phospholipid composition and function of surfactant in horses with recurrent airway obstruction (RAO) at various clinical stages and compare these properties with findings in horses without RAO. Animals—7 horses with confirmed RAO and 7 without RAO (non-RAO horses). Procedures—Pairs of RAO-affected and non-RAO horses were evaluated before, during, and after exposure to hay. Evaluations included clinical scoring, lung function testing, airway endoscopy, and bronchoalveolar lavage fluid (BALF) absolute and differential cell counts. Cell-free BALF was separated into crude surfactant pellet and supernatant by ultracentrifugation, and phospholipid and protein concentrations were determined. Phospholipid composition of crude surfactant pellets and surface tension were evaluated with high-performance liquid chromatography and a pulsating bubble surfactometer, respectively. Findings were compared statistically via mixed-effects, repeated-measures ANOVA. Results—Total phospholipid concentration in BALF was lower in RAO-affected versus non-RAO horses at all sample collection times. In the RAO-affected group, total phospholipid concentration was lower during exposure to hay than before or after exposure. There were no significant differences in BALF protein concentration, percentages of phospholipid classes, or surface tension between or within groups of horses. Conclusions and Clinical Relevance—All clinical stages of RAO-affected horses were characterized by low surfactant concentration in BALF. Exacerbation of RAO led to an additional decrease in surfactant concentration. Causes for low surfactant concentration in RAO-affected horses remain to be determined. Low phospholipid concentration may render RAO-affected horses more susceptible than unaffected horses to surfactant alterations and contribute to clinical disease status and progression.Keywords
This publication has 30 references indexed in Scilit:
- Current perspectives in pulmonary surfactant — Inhibition, enhancement and evaluationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Surfactant in Airway DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspirationRespiratory Research, 2007
- European consensus guidelines on the management of neonatal respiratory distress syndromejpme, 2007
- Surfactant as an Airway Smooth Muscle RelaxantAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Immunoregulatory functions of surfactant proteinsNature Reviews Immunology, 2005
- Pulmonary surfactant: functions, abnormalities and therapeutic optionsIntensive Care Medicine, 2001
- Suppression of neural activity of bronchial irritant receptors by surface‐active phospholipid in comparison with topical drugs commonly prescribed for asthmaClinical & Experimental Allergy, 2000
- Pulmonary surfactant in health and human lung diseases: state of the artEuropean Respiratory Journal, 1999
- Effect of artificial surfactant on ciliary beat frequency in guinea pig tracheaRespiration Physiology, 1991